ZA896980B - Peptide compounds - Google Patents

Peptide compounds

Info

Publication number
ZA896980B
ZA896980B ZA896980A ZA896980A ZA896980B ZA 896980 B ZA896980 B ZA 896980B ZA 896980 A ZA896980 A ZA 896980A ZA 896980 A ZA896980 A ZA 896980A ZA 896980 B ZA896980 B ZA 896980B
Authority
ZA
South Africa
Prior art keywords
peptide compounds
derivatives
pentapeptides
termini
inhibition
Prior art date
Application number
ZA896980A
Other languages
English (en)
Inventor
Ole Didrik Laerum
Didrik Laerum Ole
Original Assignee
Hafslund Nycomed Bioreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Bioreg filed Critical Hafslund Nycomed Bioreg
Publication of ZA896980B publication Critical patent/ZA896980B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA896980A 1988-09-16 1989-09-13 Peptide compounds ZA896980B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821785A GB8821785D0 (en) 1988-09-16 1988-09-16 Peptide compounds

Publications (1)

Publication Number Publication Date
ZA896980B true ZA896980B (en) 1990-06-27

Family

ID=10643722

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896980A ZA896980B (en) 1988-09-16 1989-09-13 Peptide compounds

Country Status (22)

Country Link
US (1) US5484770A (fr)
EP (2) EP0434718A1 (fr)
JP (1) JPH04500666A (fr)
KR (1) KR900701828A (fr)
CN (1) CN1041159A (fr)
AT (1) ATE110742T1 (fr)
AU (1) AU641366B2 (fr)
CA (1) CA1339947C (fr)
DE (1) DE68917837T2 (fr)
DK (1) DK39591D0 (fr)
ES (1) ES2058479T3 (fr)
GB (1) GB8821785D0 (fr)
GE (1) GEP19971041B (fr)
HU (2) HU895788D0 (fr)
IE (1) IE64181B1 (fr)
LT (1) LT3714B (fr)
LV (1) LV10108B (fr)
MY (1) MY104909A (fr)
NZ (1) NZ230654A (fr)
RU (1) RU2079509C1 (fr)
WO (1) WO1990002753A1 (fr)
ZA (1) ZA896980B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (fr) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (el) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Αιμορυ?μιστικά πεπτίδια.
CN1034735C (zh) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 血调节肽
US5521284A (en) * 1994-08-01 1996-05-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide amides and esters
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
CN1403474A (zh) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 一种短肽及以其为活性成份的药物
WO2004009616A2 (fr) * 2002-07-23 2004-01-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Analogues de la ghreline

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
DK39591A (da) 1991-03-06
KR900701828A (ko) 1990-12-04
ES2058479T3 (es) 1994-11-01
EP0359338A1 (fr) 1990-03-21
MY104909A (en) 1994-06-30
LTIP610A (en) 1994-12-27
EP0359338B1 (fr) 1994-08-31
HU208027B (en) 1993-07-28
US5484770A (en) 1996-01-16
NZ230654A (en) 1991-10-25
GB8821785D0 (en) 1988-10-19
DK39591D0 (da) 1991-03-06
ATE110742T1 (de) 1994-09-15
DE68917837D1 (de) 1994-10-06
LV10108A (lv) 1994-05-10
WO1990002753A1 (fr) 1990-03-22
EP0434718A1 (fr) 1991-07-03
CA1339947C (fr) 1998-07-07
DE68917837T2 (de) 1994-12-22
RU2079509C1 (ru) 1997-05-20
LT3714B (en) 1996-02-26
IE64181B1 (en) 1995-07-12
GEP19971041B (en) 1997-11-26
HU895788D0 (en) 1991-08-28
CN1041159A (zh) 1990-04-11
AU641366B2 (en) 1993-09-23
LV10108B (en) 1994-10-20
IE892954L (en) 1990-03-16
HUT58765A (en) 1992-03-30
AU4218389A (en) 1990-04-02
JPH04500666A (ja) 1992-02-06

Similar Documents

Publication Publication Date Title
CA2270289A1 (fr) Proteines a concentration amelioree en acides amines essentiels
EP0212474A3 (fr) Peptides osseux morphogénétiques
HU891841D0 (en) Process for preparation of amino-acid-n-carboxy-anhydrides protected with urethane group
EP0182372A3 (fr) Polypeptides facteur VIII coagulant
GB8821785D0 (en) Peptide compounds
KR0180256B1 (en) Bpc peptides, their preparation and use
EP0225020A3 (fr) Peptides comprenant dans leur séquence des unités sélectionnées parmi les restes d'acides aminés 17 à 24 du VIP
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
DE3569541D1 (en) Pharmacologically active peptides
AU585167B2 (en) Novel substrate peptides
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
CA2163805A1 (fr) Nouveau facteur d'activation des leucocytes
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
GB9604518D0 (en) Novel compounds
EP0290029A3 (fr) (19-Alanine) calcitonine